Metropolis Healthcare

Price chart

Previous close

₹576.90

Open

₹575.50

Day high

₹587.00

Day low

₹570.50

Listed on NSE since 15 April 2019.

Market value

₹11,972 Cr

P/E (trailing)

53.57

EPS (trailing)

₹10.77

Price to book

7.27

Dividend yield

0.35%

Return on equity

14.6%

Debt to equity

0.16

Profit margin

12.6%

Beta

0.22

Volume today

1.03 L

Average volume

2.53 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Metropolis Healthcare’s results filed with NSE, consolidated (the whole group). Net profit is the share of Metropolis Healthcare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss. EPS before Q4 FY26 is not shown: the share count changed (a bonus, split or merger), so it would not compare.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Metropolis Healthcare’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

Industry

Diagnostics & Research

Based in

Mumbai

Employees

4,484

Company website · Profile: Yahoo Finance

No headlines name Metropolis Healthcare in the last day or two.

• Interim Dividend - Re 1 Per Share

  Dividend · ex-date 9 November 2026

• Interim Dividend - Re 1 Per Share

  Dividend · ex-date 19 May 2026

• Bonus 3:1

  Bonu · ex-date 20 March 2026

• Interim Dividend - Rs 4 Per Share

  Dividend · ex-date 11 November 2025

• Interim Dividend - Rs 4 Per Share

  Dividend · ex-date 17 November 2023

• Annual General Meeting

  Action · ex-date 10 August 2023

• Interim Dividend - Rs 8 Per Share

  Dividend · ex-date 23 February 2023

• Annual General Meeting

  Action · ex-date 8 August 2022

Source: NSE. Latest first, 8 of 11.